TC
ALBO

TFS Capital’s Albireo Pharma Inc ALBO Stock Holding History

TFS Capital’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-467
Closed -$23K – 1193
2014
Q3 		$23K Sell
467
-2,374
-84% -$136K ﹤0.01% 1017
2014
Q2 		$184K Sell
2,841
-7,635
-73% -$531K 0.01% 961
2014
Q1 		$858K Buy
10,476
+8,058
+333% +$733K 0.06% 521
2013
Q4 		$165K Sell
2,418
-1,712
-41% -$125K 0.01% 1326
2013
Q3 		$390K Buy
4,130
+3,234
+361% +$421K 0.02% 991
2013
Q2 		$112K Buy
+896
New +$93.2K ﹤0.01% 1416

Other funds holding ALBO

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FMA
FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

TFS Capital's ALBO Position: Q4 2014 in Review

TFS Capital sold out of Albireo Pharma Inc (ALBO) in Q4 2014, closing a stake of 467 shares — an estimated $23K sold.

TFS Capital first reported a position in ALBO in Q2 2013 and held it in 6 quarters. The position peaked at $858K in Q1 2014. 35 funds tracked by Wall St. Rank hold ALBO as of Q4 2014.

  • TFS Capital reported no remaining Albireo Pharma Inc position as of Q4 2014 after selling out during the quarter.
  • TFS Capital sold 467 Albireo Pharma Inc shares in Q4 2014, an estimated $23K.
  • TFS Capital first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 6 quarters.
  • TFS Capital's Albireo Pharma Inc position peaked at $858K in Q1 2014.
  • 35 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2014.

Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.